Burmester, Gerd
Drescher, Edit
Hrycaj, Pawel
Chien, David
Pan, Zhiying
Cohen, Stanley
Funding for this research was provided by:
Amgen (NCT02792699)
Article History
Received: 22 January 2020
Revised: 3 July 2020
Accepted: 21 July 2020
First Online: 2 September 2020
Change Date: 23 September 2020
Change Type: Correction
Change Details: This article originally published with the family name and given names of all authors transposed.
Compliance with ethical standards
:
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
: Medical writing assistance was provided by Sabby Muneer, PhD, Innovation Communications Group, New York, NY under the guidance of Monica Ramchandani, PhD, Amgen Inc.
: • Gerd Burmester received consulting fees from Amgen, Sandoz, and Biogen; has received speaker honoraria from Biogen.• Edit Drescher has no conflicts of interest to disclose.• Pawel Hrycaj has no conflicts of interest to disclose.• David Chien is an employee and stockholder of Amgen, Inc.• Zhiying Pan is an employee and stockholder of Amgen, Inc.• Stanley Cohen has received consulting fees as well as grant and research support from Amgen Inc., Abbvie, Boehringer-Ingelheim, Genentech, Lilly, and Pfizer.